In luminal-like early breast cancer (BC), the lack of Progesterone Receptor (PR) expression generally correlates with more aggressive behavior but the clinical validity of low PR levels remains a debated issue.
Prognostic Relevance of Progesterone Receptor Levels in Early Luminal-Like HER2 Negative Breast Cancer Subtypes: A Retrospective Analysis / Diana, A., Carlino, F., Buono, G., Antoniol, G., Famiglietti, V., De Angelis, C., Carrano, S., Piccolo, A., De Vita, F., Ciardiello, F., Bruno, D., Arpino, G., Orditura, M.. - In: FRONTIERS IN ONCOLOGY. - ISSN 2234-943X. - 12:(2022), p. 813462. [10.3389/fonc.2022.813462]
Prognostic Relevance of Progesterone Receptor Levels in Early Luminal-Like HER2 Negative Breast Cancer Subtypes: A Retrospective Analysis
Carlino, Francesca;De Angelis, Carmine;Carrano, Simone;Piccolo, Antonio;Daniele, Bruno;Arpino, Grazia;
2022
Abstract
In luminal-like early breast cancer (BC), the lack of Progesterone Receptor (PR) expression generally correlates with more aggressive behavior but the clinical validity of low PR levels remains a debated issue.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
